February 5, 2026 |
Yext, Inc. (YEXT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Yext, Inc. (“Yext” or “the Company”) (NYSE: YEXT). Investors who purchased Yext securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Yext has violated federal… read more
February 4, 2026 |
Pharming Group N.V. (PHAR)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pharming Group N.V. (“Pharming” or “the Company”) (NASDAQ: PHAR). Investors who purchased Pharming securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Pharming has violated… read more
February 4, 2026 |
Galaxy Digital Inc. (GLXY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Galaxy Digital Inc. (“Galaxy” or “the Company”) (NASDAQ: GLXY). Investors who purchased Galaxy securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Galaxy has violated… read more
February 4, 2026 |
Graphic Packaging Holding Company (GPK)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Graphic Packaging Holding Company (“Graphic Packaging” or “the Company”) (NYSE: GPK). Investors who purchased Graphic Packaging securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
February 2, 2026 |
PennyMac Financial Services, Inc. (PFSI)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PennyMac Financial Services, Inc. (“PennyMac” or “the Company”) (NYSE: PFSI). Investors who purchased PennyMac securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PennyMac has… read more
January 30, 2026 |
Vizsla Silver Corp. (VZLA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vizsla Silver Corp. (“Vizsla” or “the Company”) (NYSE: VZLA). Investors who purchased Vizsla securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Vizsla has violated… read more
January 30, 2026 |
Microsoft Corporation (MSFT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Microsoft Corporation (“Microsoft” or “the Company”) (NASDAQ: MSFT). Investors who purchased Microsoft securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Microsoft has violated federal… read more
January 29, 2026 |
Carvana Co. (CVNA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carvana Co. (“Carvana” or “the Company”) (NYSE: CVNA). Investors who purchased Carvana securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Carvana has violated federal… read more
January 28, 2026 |
Danone S.A. (DANOY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Danone S.A. (“Danone” or “the Company”) (OTCMKTS: DANOY). Investors who purchased Danone securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Danone has violated federal… read more
January 28, 2026 |
Brown & Brown, Inc. (BRO)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brown & Brown, Inc. (“Brown & Brown” or “the Company”) (NYSE: BRO). Investors who purchased Brown & Brown securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
January 27, 2026 |
Capital One Financial Corporation (COF)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capital One Financial Corporation (“Capital One” or “the Company”) (NYSE: COF). Investors who purchased Capital One securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
January 27, 2026 |
First Citizens BancShares, Inc. (FCNCA)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Citizens BancShares, Inc. (“First Citizens” or “the Company”) (NASDAQ: FCNCA). Investors who purchased First Citizens securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
January 27, 2026 |
T1 Energy Inc. (TE)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of T1 Energy Inc. (“T1” or “the Company”) (NYSE: TE). Investors who purchased T1 securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether T1 has violated… read more
January 26, 2026 |
Telesat Corporation (TSAT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telesat Corporation (“Telesat” or “the Company”) (NASDAQ: TSAT). Investors who purchased Telesat securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Telesat has violated federal… read more
January 23, 2026 |
Newegg Commerce, Inc. (NEGG)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Newegg Commerce, Inc. (“Newegg” or “the Company”) (NASDAQ: NEGG). Investors who purchased Newegg securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Newegg has violated… read more
January 22, 2026 |
PDD Holdings Inc. (PDD)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PDD Holdings Inc. (“PDD” or “the Company”) (NASDAQ: PDD). Investors who purchased PDD securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PDD has violated… read more
January 20, 2026 |
Lantheus Holdings, Inc. (LNTH)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH). Investors who purchased Lantheus securities prior to November 6, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
January 20, 2026 |
Lineage, Inc. (LINE)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE). Investors who purchased Lineage securities prior to July 25, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
January 19, 2026 |
Skye Bioscience, Inc. (SKYE)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE). Investors who purchased Skye securities prior to November 4, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
January 16, 2026 |
Phoenix Education Partners, Inc. (PXED)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phoenix Education Partners, Inc. (“Phoenix” or “the Company”) (NYSE: PXED). Investors who purchased Phoenix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phoenix has… read more
January 14, 2026 |
Wealthfront Corporation (WLTH)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wealthfront Corporation (“Wealthfront” or “the Company”) (NASDAQ: WLTH). Investors who purchased Wealthfront securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Wealthfront has violated federal… read more
January 14, 2026 |
Teleflex Incorporated (TFX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated (“Teleflex” or “the Company”) (NYSE: TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Teleflex has violated federal… read more
January 13, 2026 |
Primo Brands Corporation (PRMB)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Primo Brands Corporation (“Primo Brands” or “the Company”) (NYSE: PRMB). Investors who purchased Primo Brands securities prior to November 11, 2024, and continue to hold to the present, are encouraged to… read more
January 13, 2026 |
Stride, Inc. (LRN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN). Investors who purchased Stride securities prior to October 22, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
January 13, 2026 |
Nutanix, Inc. (NTNX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutanix, Inc. (“Nutanix” or “the Company”) (NASDAQ: NTNX). Investors who purchased Nutanix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nutanix has violated federal… read more
January 12, 2026 |
Nestlé S.A. (NSRGY)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nestlé S.A. (“Nestlé” or “the Company”) (OTCMKTS: NSRGY). Investors who purchased Nestlé securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nestlé has violated federal… read more
January 12, 2026 |
Beta Bionics, Inc. (BBNX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (NASDAQ: BBNX). Investors who purchased Beta Bionics securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Beta… read more
January 9, 2026 |
CarMax, Inc. (KMX)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX). Investors who purchased CarMax securities prior to June 20, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
January 9, 2026 |
Synopsys, Inc. (SNPS)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS). Investors who purchased Synopsys securities prior to December 4, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
January 9, 2026 |
Avantor, Inc. (AVTR)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR). Investors who purchased Avantor securities prior to March 5, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more